Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Swartz

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
Psychiatric Services (Washington, D.C.)|October 5, 2010
Reductions in arrest under assisted outpatient treatment in New YorkAllison R Gilbert, Lorna L Moser, Richard A Van Dorn, et al.
Schizophrenia Research|November 26, 2008
Results of phase 3 of the CATIE schizophrenia trialT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of SchizophreniaRobert A Rosenheck, Douglas L Leslie, Kyaw J Sint, et al.
Archives of General Psychiatry|May 3, 2006
A national study of violent behavior in persons with schizophreniaJeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Comparison of antipsychotic medication effects on reducing violence in people with schizophreniaJeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Journal of Anxiety Disorders|August 27, 2014
Cortical surface anatomy in pediatric patients with generalized anxiety disorderJeffrey R Strawn, C John Wegman, Kelli C Dominick, et al.
Psychiatric Services (Washington, D.C.)|April 5, 2022
Building Bridges Between Evidence and Policy in Mental Health Services Research: Introducing the Policy Review Article TypeMatthew L Goldman, Marvin S Swartz, Grayson S Norquist, et al.
The Journal of the American Academy of Psychiatry and the Law|April 17, 2019
Criminal Justice and Suicide Outcomes with Indiana's Risk-Based Gun Seizure LawJeffrey W Swanson, Michele M Easter, Kelly Alanis-Hirsch, et al.
The American Journal of Psychiatry|July 20, 2011
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)T Scott Stroup, Joseph P McEvoy, Kimberly D Ring, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
Psychiatric Services (Washington, D.C.)|October 5, 2010
Reductions in arrest under assisted outpatient treatment in New YorkAllison R Gilbert, Lorna L Moser, Richard A Van Dorn, et al.
Schizophrenia Research|November 26, 2008
Results of phase 3 of the CATIE schizophrenia trialT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of SchizophreniaRobert A Rosenheck, Douglas L Leslie, Kyaw J Sint, et al.
Archives of General Psychiatry|May 3, 2006
A national study of violent behavior in persons with schizophreniaJeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Comparison of antipsychotic medication effects on reducing violence in people with schizophreniaJeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Journal of Anxiety Disorders|August 27, 2014
Cortical surface anatomy in pediatric patients with generalized anxiety disorderJeffrey R Strawn, C John Wegman, Kelli C Dominick, et al.
Psychiatric Services (Washington, D.C.)|April 5, 2022
Building Bridges Between Evidence and Policy in Mental Health Services Research: Introducing the Policy Review Article TypeMatthew L Goldman, Marvin S Swartz, Grayson S Norquist, et al.
The Journal of the American Academy of Psychiatry and the Law|April 17, 2019
Criminal Justice and Suicide Outcomes with Indiana's Risk-Based Gun Seizure LawJeffrey W Swanson, Michele M Easter, Kelly Alanis-Hirsch, et al.
The American Journal of Psychiatry|July 20, 2011
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)T Scott Stroup, Joseph P McEvoy, Kimberly D Ring, et al.
Pageof 27